Dentsply Sirona (XRAY) EBITDA (2009 - 2026)

Dentsply Sirona (XRAY) has reported EBITDA for 18 consecutive years, with $82.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA rose 164.06% year-over-year to $82.0 million; the trailing twelve-month figure through Jun 2026 stood at -$310.0 million (up 70.08% YoY), and the FY2025 full-year result was -$422.0 million, up 51.99% from the prior year.
• EBITDA climbed to $82.0 million in Q2 2026 per XRAY's latest filing, from -$35.0 million in the prior quarter.
• Across five years, EBITDA topped out at $119.0 million in Q2 2022 and bottomed at -$1.2 billion in Q3 2022.
• Historically, EBITDA has averaged -$126.4 million across 5 years, with a median of $20.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: EBITDA tumbled 1022.73% in 2022, then surged 2200.0% in 2024.
• Over 5 years, EBITDA stood at $65.0 million in 2022, then gained by 12.31% to $73.0 million in 2023, then tumbled by 797.26% to -$509.0 million in 2024, then jumped by 72.69% to -$139.0 million in 2025, then surged by 158.99% to $82.0 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $82.0 million, -$35.0 million, and -$139.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.